1. Company Directors - P
2. Pykett Mark Jerome

Insider Trading History of Pykett Mark Jerome

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Pykett Mark Jerome since 2005. The trader's CIK number is 1278271. At the time of the last reporting, Pykett Mark Jerome was the Director of Navidea Biopharmaceuticals, Inc.. (stock ticker symbol NAVB). Also see all insider trading activities at Navidea Biopharmaceuticals, Inc..

Note that in the past PYKETT MARK JEROME also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Savara Inc (ANX) by Pykett Mark Jerome

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2005	ANX	3,000	$5,085	0	$0	0	$0
2004	ANX	500	$1,040	0	$0	0	$0

Yearly summary of insider trading at Navidea Biopharmaceuticals, Inc. (NAVB) by Pykett Mark Jerome

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2014	NAVB	10,000	$13,400	120,000	$235,200	0	$0
2013	NAVB	12,750	$19,710	0	$0	0	$0
2012	NAVB	4,000	$10,552	0	$0	0	$0
2011	NAVB	4,400	$11,365	0	$0	0	$0

Insider trading activities at 2 companies by Pykett Mark Jerome:

1. Savara Inc (ANX)

2. Navidea Biopharmaceuticals, Inc. (NAVB)

Table 1. Insider trading of Savara Inc (ANX) by Pykett Mark Jerome

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2004-05-24	ANX	Buy	500	2.08	1,040
2005-04-06	ANX	Buy	3,000	1.70	5,085

Table 2. Insider trading of Navidea Biopharmaceuticals, Inc. (NAVB) by Pykett Mark Jerome

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2014-05-09	NAVB	Buy	10,000	1.34	13,400
2014-03-10	NAVB	Sale	120,000	1.96	235,200
2013-11-08	NAVB	Buy	10,900	1.35	14,715
2013-03-15	NAVB	Buy	1,850	2.70	4,995
2012-09-11	NAVB	Buy	4,000	2.64	10,552
2011-08-22	NEOP	Buy	4,400	2.58	11,365

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pykett Mark Jerome (Director of Navidea Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month